StreetAlpha
13F holdings · Q3 2026

Seven Fleet Capital Management

Mountain View, CA · files as Seven Fleet Capital Management LP
Know the moment Seven Fleet Capital Management filesYou follow Seven Fleet Capital Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 2092021

Seven Fleet Capital Management reported 85 stocks worth $512M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are CGON (26.1%), TNGX (10.9%) and RVMD (10.6%). Compared with Q2 2026, the fund opened new positions in DMRA, IMUX and UTHR, added to RVMD, ENTX and LQDA, trimmed TNGX, PHVS and ELVN and sold out of MIRM, MDGL and RLMD.

Latest filing: what Seven Fleet Capital Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
20 new27 added30 trimmed31 sold outBought about $76.3M · sold about $113M
New 20
See all 20 →
Added 27
See all 27 →
Trimmed 30
See all 30 →
Sold out 31
See all 31 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$512M−15.5% vs last quarter
Stocks held8520 new · 31 sold out
Top 5 weight55.9%fairly concentrated
Turnover37%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 4 qtrsHeld
1
CGON
CG Oncology Inc
$134M26.1%1.9MNo change4 of 4
2
TNGX
Tango Therapeutics Inc
$55.7M10.9%2.2M−995K (−31%)4 of 4
3
RVMD
Revolution Medicines Inc
$54.3M10.6%265K+23K (+9%)4 of 4
4
PHVS
Pharvaris N V
$22.2M4.3%700K−74K (−10%)4 of 4
5
ENTX
Entera Bio Ltd
$20M3.9%6.9M+6.7M (+3486%)4 of 4
6
LQDA
Liquidia Corporation
$18M3.5%596K+340K (+132%)4 of 4
7
AVBP
Arrivent Biopharma Inc
$13.7M2.7%451K+205K (+83%)3 of 4
8
ELVN
Enliven Therapeutics Inc
$12M2.4%262K−103K (−28%)4 of 4
9
AVTX
Avalo Therapeutics Inc
$11.8M2.3%773K+1,895 (+0%)4 of 4
10
XNCR
Xencor Inc
$11.1M2.2%445K+77K (+21%)4 of 4
🔒 75 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
MIRM
Mirum Pharmaceuticals Inc
$12.9M110K
GALECTO INC
$7.4M284K
MDGL
Madrigal Pharmaceuticals Inc
$2.7M4,973
RLMD
Relmada Therapeutics Inc
$2.4M348K
AGIO
Agios Pharmaceuticals Inc
$2.1M57K

🔒 Free account: see all 30.

Reported value

last 4 quarters
$148MQ4 '25
$318MQ1 '26
$606MQ2 '26
$512MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Seven Fleet Capital Management 13F FAQ

What does Seven Fleet Capital Management own?

Seven Fleet Capital Management reported 85 stocks worth $512M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are CGON (26.1%), TNGX (10.9%) and RVMD (10.6%). The table above lists every position in the filing (the top 10 without an account).

What did Seven Fleet Capital Management buy and sell in Q3 2026?

Compared with Q2 2026: 20 new positions, 27 added to, 30 trimmed and 31 sold out. New positions include DMRA, IMUX and UTHR. It sold all of MIRM, MDGL and RLMD.

When will Seven Fleet Capital Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Seven Fleet Capital Management's portfolio worth?

The Q3 2026 filing reports $512M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.